ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 370 out of 1454

$582K Total Retail Price of All Prescriptions

Rank: 339 out of 1454

259 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 259 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 259 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 8,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 385 338 1 6
OMEPRAZOLE 318 296 2 3
AMLODIPINE BESYLATE 309 300 3 2
WARFARIN SODIUM 286 284 4 17
LISINOPRIL 268 250 5 4
METOPROLOL TARTRATE 262 249 6 10
NAMENDA 255 254 7 48
SIMVASTATIN 253 226 8 1
FENTANYL 169 168 S2 9 104
LEVOTHYROXINE SODIUM 166 161 10 5
GABAPENTIN 159 123 11 16
HYDRALAZINE HCL 155 151 12 67
MIRTAZAPINE 150 150 13 53
POTASSIUM CHLORIDE 150 136 13 15
GLIPIZIDE 135 120 15 62
TRAMADOL HCL 127 89 16 20
OXYCODONE-ACETAMINOPHEN 127 126 S2 16 60
EXELON 124 115 18 135
ISOSORBIDE MONONITRATE ER 124 121 18 46
SERTRALINE HCL 118 102 20 26
POLYETHYLENE GLYCOL 3350 107 98 21 61
ISOSORBIDE DINITRATE 105 96 22 254
DONEPEZIL HCL 104 104 23 29
PANTOPRAZOLE SODIUM 103 87 24 31
LANTUS 99 94 25 51
TRAZODONE HCL 97 67 26 50
HYDROCODONE-ACETAMINOPHEN 97 76 S3 26 7
DIOVAN 90 86 28 40
NOVOLIN R 89 76 29 180
PREDNISONE 88 79 30 36
HYDROCHLOROTHIAZIDE 87 83 31 9
CLONIDINE HCL 86 84 32 49
DIGOXIN 86 82 32 70
CARVEDILOL 79 78 34 24
RISPERIDONE 77 66 35 86
ATORVASTATIN CALCIUM 66 57 36 11
LIDODERM 65 59 37 158
NEXIUM 63 50 38 23
ATENOLOL 60 60 39 18
KLOR-CON M10 60 59 39 145
METFORMIN HCL 56 48 41 8
CLOPIDOGREL 55 49 42 32
CITALOPRAM HBR 50 38 43 21
CEFTRIAXONE 50 50 43 213
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.